Magellan Health (MGLN) Misses Q1 EPS by 1c; Updates EPS Outlook

Magellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.54, $0.01 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Magellan Health sees FY2016 EPS of $3.19-$3.96, versus the consensus of $2.74.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
• Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance